These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 4042090)
1. Policies for interim analysis and interim reporting of results. O'Fallon JR Cancer Treat Rep; 1985 Oct; 69(10):1101-6. PubMed ID: 4042090 [TBL] [Abstract][Full Text] [Related]
3. The design and conduct of randomized clinical trials. Gordon RS IRB; 1985; 7(1):1-3, 12. PubMed ID: 11649616 [No Abstract] [Full Text] [Related]
4. Ethical issues in cooperative cancer therapy trials from a statistical viewpoint. II. Specific issues. Shuster JJ; Krischer JP; Boyett JM Am J Pediatr Hematol Oncol; 1985; 7(1):64-70. PubMed ID: 4037245 [TBL] [Abstract][Full Text] [Related]
5. The ethical approach to randomization in oncology. Arpaillange P; Dion S Drugs Exp Clin Res; 1986; 12(1-3):99-103. PubMed ID: 3732058 [No Abstract] [Full Text] [Related]
6. Ethical communication in clinical trials. Issues faced by data managers in obtaining informed consent. Loh WY; Butow PN; Brown RF; Boyle F Cancer; 2002 Dec; 95(11):2414-21. PubMed ID: 12436450 [TBL] [Abstract][Full Text] [Related]
8. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171 [TBL] [Abstract][Full Text] [Related]
9. [The use of state of the art statistical methodology in biomedical research: the example of methodology for interim analyses in clinical trials]. Muñoz SR; Bangdiwala SI Rev Med Chil; 2001 Sep; 129(9):983-8. PubMed ID: 11725478 [TBL] [Abstract][Full Text] [Related]
10. Experimental evidence and social policy: foreword. Mosteller F Milbank Mem Fund Q Health Soc; 1981; 59(3):297-307. PubMed ID: 7024845 [No Abstract] [Full Text] [Related]
11. Clinical trials: I. Design and ethical issues. Tilley B Henry Ford Hosp Med J; 1984; 32(2):147-51. PubMed ID: 6511453 [No Abstract] [Full Text] [Related]
12. Inventors as investigators: the ethics of patents in clinical trials. Kimmelman J Acad Med; 2007 Jan; 82(1):24-31. PubMed ID: 17198287 [TBL] [Abstract][Full Text] [Related]
13. Policy and ethical issues in applying medical biotechnology in developing countries. Bhardwaj M; Macer DR Med Sci Monit; 2003 Feb; 9(2):RA49-54. PubMed ID: 12601306 [TBL] [Abstract][Full Text] [Related]
14. The ethics of health communication. Strasser T; Gallagher J World Health Forum; 1994; 15(2):175-7. PubMed ID: 8018285 [TBL] [Abstract][Full Text] [Related]
15. Ethical problems in clinical trials concerning minimal residual tumors. Dion S; Reizenstein P Suppl J Med Oncol Tumor Pharmacother; 1988; 1():99-102. PubMed ID: 3074231 [No Abstract] [Full Text] [Related]
16. Ethical problems in clinical trials concerning minimal residual tumors. Dion S; Reizenstein P Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):99-102. PubMed ID: 2743535 [No Abstract] [Full Text] [Related]
17. [Ethics of randomization]. Arpaillange P; Dion S Biomed Pharmacother; 1984; 38(9-10):426-9. PubMed ID: 6529599 [No Abstract] [Full Text] [Related]
18. Survival end point reporting in randomized cancer clinical trials: a review of major journals. Mathoulin-Pelissier S; Gourgou-Bourgade S; Bonnetain F; Kramar A J Clin Oncol; 2008 Aug; 26(22):3721-6. PubMed ID: 18669458 [TBL] [Abstract][Full Text] [Related]
19. Judgement and decision in oncology. Tubiana M Bull Cancer; 1980; 67(4):369-73. PubMed ID: 7225594 [No Abstract] [Full Text] [Related]
20. Stopping clinical trials early for benefit: impact on estimation. Freidlin B; Korn EL Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]